Related Experiment Video
Updated: Nov 16, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Abstract:
In 2020, the FDA approved 17 novel cancer drugs. The agency also authorized the use of several cancer therapeutics for new indications.
Insights
In 2020, the U.S. Food and Drug Administration (FDA) approved 17 new cancer drugs and expanded the use of existing cancer treatments. This signifies advancements in oncology drug development and therapeutic options for patients.
Area of Science:
- Oncology
- Drug Development
- Regulatory Science
Background:
- In 2020, the U.S. Food and Drug Administration (FDA) played a crucial role in advancing cancer care.
- The agency's actions directly impacted the availability of novel therapeutics for oncological conditions.
Discussion:
- The FDA's 2020 approvals highlight a dynamic period in cancer drug innovation.
- These approvals represent significant progress in addressing unmet needs in cancer treatment.
Key Insights:
- Seventeen novel cancer drugs received FDA approval in 2020.
- Several existing cancer therapeutics were authorized for new indications, expanding treatment options.
Outlook:
- The trend of novel drug approvals suggests continued innovation in cancer therapy.
- Future research and regulatory reviews will likely focus on expanding the utility of these and other cancer treatments.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Regulation
Clinical Trials: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

